The DOI matches its Crossref record; 74 of the 75 references it cites were found in a registry or an index.
Optimal Strategies for Colorectal Cancer Screening
Open accessAbstract
Opinion statement: Colorectal cancer (CRC) imposes significant morbidity and mortality, yet it is also largely preventable with evidence-based screening strategies. In May 2021, the US Preventive Services Task Force updated guidance, recommending screening begin at age 45 for average-risk individuals to reduce CRC incidence and mortality in the United States (US). The Task Force recommends screening with one of several screening strategies: high-sensitivity guaiac fecal occult blood test (HSgFOBT), fecal immunochemical test (FIT), multi-target stool DNA (mt-sDNA) test, computed tomographic (CT) colonography (virtual colonoscopy), flexible sigmoidoscopy, flexible sigmoidoscopy with FIT, or traditional colonoscopy. In addition to these recommended options, there are several emerging and novel CRC screening modalities that are not yet approved for first-line screening in average-risk individuals. These include blood-based screening or “liquid biopsy,” colon capsule endoscopy, urinary metabolomics, and stool-based microbiome testing for the detection of colorectal polyps and/or CRC. In order to maximize CRC screening uptake in the US, patients and providers should engage in informed decision-making about the benefits and limitations of recommended screening options to determine the most appropriate screening test. Factors to consider include the invasiveness of the test, test performance, screening interval, accessibility, and cost. In addition, health systems should have a programmatic approach to CRC screening, which may include evidence-based strategies such as patient education, provider education, mailed screening outreach, and/or patient navigation, to maximize screening participation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“There is some debate, in which, on the one hand, there is no doubt about the logical concept that screening is necessary to detect precancerous changes and early forms of cancer and to reduce mortality from CRC[22-25].”
From Risk factors, prevention and screening of colorectal cancer: A rising problem (2025) · cites this paper as [25]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Screening for Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement
U.S. Preventive Services Task Force* (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-9-200811040-00243 · Cited by 1,959
Wolf, A. M. D., Fontham, E. T. H., Church, T. R., Flowers, C. R., Guerra, C. E., LaMonte, S. J., Etzioni, R., McKenna, M. T., Oeffinger, K. C., Shih, Y. T., et al. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21457 · Cited by 1,944
Multitarget Stool DNA Testing for Colorectal-Cancer Screening
Imperiale, T. F., Ransohoff, D. F., Itzkowitz, S. H., Levin, T. R., Lavin, P., Lidgard, G. P., Ahlquist, D. A., & Berger, B. M. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1311194 · Cited by 1,900
Long-term colorectal-cancer incidence and mortality after lower endoscopy
Nishihara, R., Wu, K., Lochhead, P., Morikawa, T., Liao, X., Qian, Z. R., Inamura, K., Kim, S. A., Kuchiba, A., Yamauchi, M., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1301969 · Cited by 1,483
Quality Indicators for Colonoscopy
Rex, D. K., Schoenfeld, P. S., Cohen, J., Pike, I. M., Adler, D. G., Fennerty, B. M., Lieb, J. G., Park, W. G., Rizk, M. K., Sawhney, M. S., et al. (2015) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.385 · Cited by 1,401
Lin, J. S., Bowles, E. J. A., Williams, S. B., & Morrison, C. C. (2017) · JAMA · doi:10.1001/jama.2017.0562 · Cited by 1,082
Colorectal Cancer Incidence Patterns in the United States, 1974–2013
Siegel, R. L., Fedewa, S. A., Anderson, W. F., Miller, K. D., Ma, J., Rosenberg, P. S., & Jemal, A. (2017) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djw322 · Cited by 1,002
ACG Clinical Guidelines: Colorectal Cancer Screening 2021
Shaukat, A., Kahi, C. J., Burke, C. A., Rabeneck, L., Sauer, B. G., & Rex, D. K. (2021) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001122 · Cited by 853
Quality Indicators for Colonoscopy
Rex, D. K., Petrini, J. L., Baron, T. H., Chak, A., Cohen, J., Deal, S. E., Hoffman, B., Jacobson, B. C., Mergener, K., Petersen, B. T., et al. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00673.x · Cited by 845
Lin, J. S., Perdue, L. A., Henrikson, N. B., Bean, S. I., & Blasi, P. R. (2021) · JAMA · doi:10.1001/jama.2021.4417 · Cited by 650
Research works printed but not linked: 1
- Kaur K, Adamski JJ. Fecal Occult Blood Test. StatPearls. Treasure Island (FL): StatPearls Publishing Copyright © 2021, StatPearls Publishing LLC; 2021.
Cited by
Colorectal Cancer: From Risk Factors to Oncogenesis
Ionescu, V. A., Gheorghe, G., Bacalbasa, N., Chiotoroiu, A. L., & Diaconu, C. (2023) · Medicina · doi:10.3390/medicina59091646 · Cited by 202
Colon Cancer Screening Methods: 2023 Update
Jayasinghe, M., Prathiraja, O., Caldera, D., Jena, R., Coffie-Pierre, J. A., Silva, M. S., & Siddiqui, O. S. (2023) · Cureus · doi:10.7759/cureus.37509 · Cited by 105
Why is early detection of colon cancer still not possible in 2023?
Tonini, V., & Zanni, M. (2024) · World Journal of Gastroenterology · doi:10.3748/wjg.v30.i3.211 · Cited by 69
Risk factors, prevention and screening of colorectal cancer: A rising problem
Tsukanov, V. V., Vasyutin, A. V., & Tonkikh, J. L. (2025) · World Journal of Gastroenterology · doi:10.3748/wjg.v31.i5.98629 · Cited by 42
Zhang, Y., Wang, L., Wu, W., Zhang, S., Zhang, M., She, W., Cheng, Q., Chen, N., Fan, P., Du, Y., et al. (2023) · International Journal of Nursing Studies · doi:10.1016/j.ijnurstu.2023.104631 · Cited by 41
Metadata
- Authors
- Jain, S., Maque, J., Galoosian, A., Osuna-Garcia, A., & May, F. P.
- Affiliations
- University of California, Los Angeles (US)
- Kaiser Permanente (US)
- Corresponding author
- May, Folasade P.
- Venue
- Current Treatment Options in Oncology
- Published
- 2022-03-22
- Volume
- 23
- Issue
- 4
- Pages
- 474-493
- ISSN
- 1527-2729 (ISSN-L)
- 1534-6277
- PMC
- PMC8989803
- OpenAlex
- W4221111564
- Semantic Scholar
- e839c93b3311ef621ad37d3be6bff89934c176b0
- Cited by
- 110
- References
- 75
- Citations by year
- 2026: 20 · 2025: 35 · 2024: 29 · 2023: 23 · 2022: 3
- FWCI
- 2.78
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Current Treatment Options in Oncology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Funders
- Jonsson Comprehensive Cancer Center
- Topics
- Health Sciences › Medicine › Oncology › Colorectal Cancer Screening and Detection
- Health Sciences › Medicine › Oncology › Colorectal Cancer Surgical Treatments
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Keywords
- colorectal cancer screening, colorectal cancer prevention, USPSTF screening recommendations, average-risk population, fecal immunochemical test, multi-target stool DNA test, CT colonography, flexible sigmoidoscopy, colonoscopy, liquid biopsy, colon capsule endoscopy, urine metabolomics, colorectal polyps, screening uptake, patient navigation, screening outreach, informed decision-making
- MeSH terms
- Colonoscopy, Humans, Mass Screening, Middle Aged, Occult Blood, Sigmoidoscopy, United States, Colorectal Neoplasms, Early Detection of Cancer
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Optimal Strategies for Colorectal Cancer Screening. https://app.cochat.ai/papers/10.1007/s11864-022-00962-4
- The paper
- Jain, S., Maque, J., Galoosian, A., Osuna-Garcia, A., & May, F. P. (2022). Optimal Strategies for Colorectal Cancer Screening. Current Treatment Options in Oncology. https://doi.org/10.1007/s11864-022-00962-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.